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Mutations in the connexin 26 gene seem to be extremely 
common in non-syndromic hereditary deafness genesis, 
especially the 35delG, but there are still only a few studies that 
describe the audiometric characteristics of patients with these 
mutations. Aim: to analyze the audiometric characteristics 
of patients with mutations in the connexin 26 gene in order 
to outline genotype-phenotype correlation. Materials 
and Methods: Tonal audiometries of 33 index cases of 
non-syndromic sensorineural hearing loss were evaluated 
and eight affected relatives. Specific molecular tests were 
carried out to analyze mutations in the connexin 26 gene. 
Experiment Design: Retrospective, cross-sectional study. 
Results: A 27.3% prevalence of mutation 35delG was found 
in the index cases and 12.5% among the relatives affected. 
In relation to hearing loss degree, 41.5% of the patients were 
found with profound hearing loss, 39% with severe HL and 
19.5% with moderate HL with homozygote and heterozygote 
patients for the 35delG predominating in the severe-moderate 
hearing losses. Conclusion: Our results suggest that the 
audiometric data associated with the molecular diagnose 
of hearing loss helped us to outline a genotype-phenotype 
correlation in ten patients with 35delG mutation. However, it 
is still necessary to run multicentric studies to verify the real 
phenotypic expression in the Brazilian population, as far as 
the 35delG mutation is concerned.
Keywords: molecular analysis, audiometry, hearing loss, 
35delg mutation.
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INTRODUCTION
It is well known that in developed countries one in 
750 births is likely to produce a child with sensorineural 
hearing impairment and it is estimated that one in 1000 
children is affected by severe deafness at birth or by the 
end of the prelingual period1. Approximately 60% of all 
causes of prelingual deafness can be attributed to genetic 
factors. Therefore, the genetic etiology is becoming in-
creasingly relevant in cases of hearing impairment and/or 
deafness. The remaining 40% are distributed over a vast 
variety of etiologies2. There are three identifiable kinds of 
inheritance pattern for the inherited deafness: autosomal 
recessive, autosomal dominant, and X-linked. From 75% 
to 85% of cases of non-syndromic prelingual deafness 
are manifested as autosomal recessive forms. Autosomal 
dominant forms account for about 15% to 25% of cases, 
and the remaining 1% to 3% are of X-linked Mendelian 
inheritance. There are also descriptions of forms which 
are inherited exclusively from the mother, corresponding 
to mitochondrial inheritance, associated or not with auto-
somal dominant inheritance2,3.
In terms of phenotype, the autosomal recessive for-
ms are more severe, being responsible for almost all forms 
of congenital deafness. These, in turn, are caused in great 
part by cochlear defects, leading to sensorineural hearing 
impairment. The autosomal dominant forms seem to con-
tribute more to cases of postlingual deafness, which are 
usually progressive, and the impairment is, in most cases, 
conductive or mixed (conductive and sensorineural)4,5.
Mutations in the conexin 26 or GJB2 - Gap Junction 
Protein Beta 2 gene, located on the long arm of chromoso-
me 13 (13q11-12), appear to be extremely common in the 
genesis of inherited non-syndromic deafness, and account 
for 34% to 50% of autosomal recessive sensorineural deaf-
ness (DFNB1) and for 10% to 37% of sporadic cases6-10.
Deletion of a guanine out of a sequence of six gua-
nines going from position 30 to position 35 in the conexin 
26 (GJB2) gene is the mutation that occurs in 60% to 80% 
of cases. This nucleotide deletion can occur at position 
35 (35delG) or at position 30 (30delG) of the gene, but 
the deletion at position 35 (35delG), genetically related 
to chromosome 13, is the more frequent one, varying be-
tween approximately 50% to 85% of the non-syndromic 
deafness cases in patients from Italy, Spain, and Israel7,11-
13. In a study with Brazilian patients14, mutations in gene 
GJB2 were found in 22% of families tested with at least one 
patient with hearing loss, and in 11.5% of cases in which 
an environmental etiology was not completely ruled out. 
In the cases in which this mutation in conexin 26 gene 
occurs, the gene product, a protein named conexin, no 
longer exerts its functions correctly, while the cochlea is 
structurally normal15.
Even though the GJB2 gene is of great importance 
in the etiology of non-syndromic sensorineural impairment, 
there are so far very few studies describing the audiometric 
characteristics of patients with mutations in the GJB2 gene 
associated with hearing loss, especially in Brazil. Accor-
ding to these studies, in patients who are homozygous for 
mutations in the GJB2 gene and mainly in those who are 
homozygous for 35delG, the hearing loss is characterized 
for being prelingual, affecting all frequencies, being non-
progressive, varying in degree from moderate to deep, 
even among impaired siblings of the same family, and not 
being associated with vestibular alterations and radiological 
abnormalities of the inner ear16,17. The present study had 
the objective of analyzing the audiometric characteristics 
of patients with mutations in the conexin 26 gene, in order 
to outline a genotype-phenotype correlation.
PATIENTS AND METHOD
During the period from March through June, 2000, 
a cross-section study was carried out, in which 33 index 
cases (23 male and 10 female) with non-syndromic sen-
sorineural hearing impairment were investigated. They 
aged between 3 and 37 years, were randomly selected at 
the Ear-Nose-Throat Outpatient Clinic. Of these index ca-
ses, eight relatives were evaluated (4 male and 4 female), 
aged 11 to 45 years, who also presented non-syndromic 
sensorineural hearing impairment. Hence, we evaluated 
33 families with at least one member with hearing loss, 
totaling 41 impaired individuals. This study was approved 
by the Research Ethics Committee, Protocol No. 4429/2000. 
The complete history of each patient was obtained to in-
vestigate age at onset of the hearing impairment, presence 
of other cases in the family, and to exclude the possibility 
of environmental causes such as, maternal-fetal infections, 
perinatal complications, meningitis, use of ototoxic drugs, 
acoustic trauma. Physical, otorhinolaryngological and sys-
temic examinations, as well as complementary tests, were 
carried out to exclude signs suggesting syndromic forms 
of hearing loss (especially craniofacial dysmorphism, skin 
disorders, anomalies of branchial, cardiac or thyroidal 
origin, vision disorders, etc.). Moreover, patients were 
submitted to ophthalmologic evaluation (including fun-
doscopy), vestibular tests and computerized tomography 
of the temporal bone. Thus, a complete clinical evaluation 
was performed to exclude patients with hearing loss cau-
sed by environmental factors, congenital malformations 
of the inner ear or genetic syndromes. The patients were 
audiologically tested by pure-tone audiometry, performed 
at the Speech Therapy Outpatient Clinic, and those with 
non-syndromic sensorineural hearing impairment classified 
as mild (25-40 dB), moderate (41-60 dB), severe (61-80 
dB) or profound (>81 dB) were included18.
Molecular analysis was carried out at the Molecular 
Biology Center, after DNA extraction from whole blood, 
done at the Genetics and Molecular Biology Research Unit, 
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using a genomic DNA extraction kit (GFXTM Genomic 
Blood DNA Purification Kit, Amersham Pharmacia Biotech 
Inc.), according to the manufacturer protocol. To detect the 
35delG mutation, the technique used was allele-specific 
polymerase chain reaction (AS-PCR) with specific primers8. 
Primers named control A (direct) and B (reverse) were also 
synthesized, for co-amplification of the GJB2 gene with a 
segment of the amelogenin gene homologous to the X-Y 
chromosome, thus being used as internal amplification 
controls19. Additionally, the PCR technique was used to 
detect the Delta (GJB6 - D13S1830) mutation, with specific 
primers20, in heterozygous samples and in those who did 
not present the 35delG mutation. The AS-PCR and PCR 
products were analyzed by electrophoresis on 1.5% aga-
rose gel in TBE 1X buffer, containing ethidium bromide, 
at a concentration of 0.5mg/mL, submitted to ultraviolet 
light to confirm that the reaction was successful, and the 
gel was photographed. The samples which did not present 
the mutations under study on both alleles, or heterozygous 
samples, were submitted to automated sequencing.
Two pairs of primers were synthesized21 and ampli-
fication of the GJB2 gene in two fragments was obtained 
by the PCR reaction prior to sequencing. The amplified 
fragments were purified using the Wizard SV Gel and PCR 
Clean-UP System Kit (PROMEGA), and the sequencing re-
actions were run in both directions in an ABI PRISMTM 377 
automated sequencer (Perkin Elmer) using the BigDyeTM 
Terminator Cycle Sequencing Kit V2.0 Ready Reaction 
(ABI PRISM/PE Biosystems). The sequences obtained were 
analyzed and compared with the normal sequence, using 
the Gene Runner V3.05 program to align the nucleotide 
sequences and the Chromas V1.45 program to edit the 
electropherograms.
The present retrospective study was submitted to 
and approved by the Research Ethics Committee, Proto-
col No. 2813/2004, in order to review the molecular and 
audiometric data of patients.
Percentages with their respective standard devia-
tions were calculated, and the results are expressed in 
% (SD%).
RESULTS
Table 1 presents the overall genotype results ob-
tained after molecular analysis performed in the 33 index 
cases and 8 affected relatives. The clinical and audiometric 
data concerning the index cases, such as gender, age, time 
of onset and degree of hearing loss, and familial recurren-
ce, are shown in Chart 1.
Therefore, we found a prevalence of 27.3% 
(SD%=7.7) for the 35delG mutation in the index cases 
analyzed (9/33), of 21.2% (SD%=5.03) of the alleles (14/66) 
with the 35delG mutation, and of 12.5% (SD%=11.69) in the 
affected relatives. For each mutation, V37I and Delta (GJB6-
D13S1830), a 3% prevalence (SD%=2.96) was found.
The audiometric tests performed in patients with 
hearing impairment (n=41) showed the following results 
with regard to degree of loss: profound - 17 patients 
(41.5%, SD%=7.69); severe - 16 patients (39.0%, SD%=7.61) 
and moderate - 8 patients (19.5%, SD%=6.18). Of the five 
patients who were homozygous for 35delG, one presented 
a profound degree (2.43%, SD%=2.40), three presented a 
severe degree (7.31%, SD%=4.06), and one patient presen-
ted a moderate degree of hearing loss (2.43%, SD%=2.40). 
Of the two patients who were heterozygous for 35delG, 
one (2.43%, SD%=2.40) presented a severe and the other 
(2.43%, SD%=2.40) a moderate degree of hearing loss. The 
patient who was a 35delG/V37I composite heterozygote 
(2.43%, SD%=2.40) and the two 35delG/Delta (GJB6-
D13S1830) composite heterozygotes (4.87%, SD%=3.36) 
presented a severe degree of hearing loss. The predo-
minant audiometric frequencies were 4000 to 8000 Hertz 
(Hz). All patients with the 35delG mutation presented 
hearing loss with prelingual onset. 
The phenotype/genotype correlation of the index 
cases and affected relatives, with the diagnosed mutation, 
is represented in Chart 2.
DISCUSSION
In the present study, we found a 27.3% prevalence 
of the 35delG mutation in the index cases analyzed, 21.2% 
of alleles with the mutation, and 12.5% in the affected re-
latives. A prevalence of 3% was also assessed for each one 
of the mutations V37I and Delta (GJB6-D13S1830), found 
in the study. These results are concordant with previous 
studies reported in the literature, conducted in several 
populations22-26. The relative contribution of the 35delG 
mutation to the non-syndromic hearing loss in these popu-
lations varied from 0% (Oman, Korea, Japan) to 70% (Italy, 
Spain, Greece), demonstrating the genetic heterogeneity 
among the different countries, even though some of these 
Table 1. Distribution of index cases (n) and affected relatives (n) in 
relation to the genotypes found by molecular analysis of the GJB2 
gene and the Delta (GJB6 - D13S1830) mutation.
Genotype
Index cases n 
(33) %
Affected relatives 
n (8) %
Homozygous 35delG 5 15.2 0 0
Heterozygous 35delG 2   6.1 0 0
Composite hetero-
zygous 35delG/V37I
1 3.0 0 0
Composite hete-
rozygous 35delG/
D(GJB6-D13S1830)
1 3.0 1 12.5
Total 9 27.3 1 12.5
No mutation 24 72.7 7 87.5
Total 33 100 8 100
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Chart 1. Clinical and audiometric data of the 33 index cases of the study and 8 affected relatives (n=41) who were submitted to molecular 
analysis of the GJB2 gene and the Delta (GJB6-D13S1830) mutation.
Index cases
(IC)
Sex
Age
(years)
Onset of 
HL
Degree of
HL
Familial Recur-
rence
Age
(years)
Degree of
HL
1 M 15 Prelingual Severe    
2 F 12 Prelingual Profund brother CI31 11 Moderate
3 M 9 Prelingual Severe    
4 F 28 Postlingual Profund    
5 F 3 Prelingual Profund    
6 M 8 Prelingual Severe    
7 M 4 Prelingual Profund    
8 F 10 Postlingual Severe    
9 M 7 Prelingual Profund    
10 M 3 Prelingual Severe    
11 M 3 Prelingual Severe    
12 M 9 Prelingual Severe    
13 F 3 Prelingual Profund    
14 M 9 Prelingual Profund    
15 M 6 Prelingual Severe    
16 M 5 Prelingual Profund    
17 F 33 Prelingual Severe
sister CI18
brotherCI19
brotherCI20
28
37
19
Moderate
Profund
Profund
21 M 37 Postlingual Profund    
22 M 8 Prelingual Severe    
23 M 15 Prelingual Severe    
24 F 3 Prelingual Severe    
25 M 4 Prelingual Profund    
26 F 9 Prelingual Moderate    
27 F 5 Prelingual Profund    
28 M 10 Prelingual Moderate mãe CI29 38 Moderate
30 M 14 Postlingual Severe    
32 M 17 Prelingual Profund sister CI33 26 Profund
34 F 14 Prelingual Severe brotherCI35 35 Severe
36 M 32 Prelingual Profund    
37 M 7 Prelingual Profund mãe CI38 45 Moderate
39 M 15 Prelingual Moderate    
40 M 6 Prelingual Severe    
41 M 16 Prelingual Moderate    
(IC)- Index cases; (M)- Male; (F)- Female; (HL)- Hearing loss 
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Chart 2. Phenotype and genotype of the index cases and affected relatives with mutations in the GJB2 gene and with the Delta (GJB6-
D13S1830) mutation
Index cases
(IC)
Onset 
HL
Degree
Mutation
Allele 1/Allele 2
Familial Recurrence
with Mutation
Degree 
1 Prelingual Severe 35delG/V37I ----- -----
10 Prelingual Severe 35delG/35delG ----- -----
15 Prelingual Severe 35delG/35delG ----- -----
23 Prelingual Severe 35delG/Normal ----- -----
24 Prelingual Severe 35delG/35delG ----- -----
25 Prelingual Profundo 35delG/35delG ----- -----
26 Prelingual Moderate 35delG/35delG ----- -----
34 Prelingual Severe
35delG/Delta(GJB6-
D13S1830)
brother CI35 
35delG/Delta(GJB6-
D13S1830)
Severe
39 Prelingual Moderate 35delG/Normal ----- -----
IC - Index cases; HL - Hearing loss 
studies were based on a small number of patients, besides 
the differences in the impairment investigation criteria and 
the mutation screening methods23,27-30.
Recent studies found a 342 thousand base-pair (342 
Kb) deletion close to the GJB6 [D(GJB6 - D13S1830)] gene, 
suggesting that this mutation could cause non-syndromic 
recessive hearing loss, either by a homozygous deletion 
or by digenic penetrance of the deletion in the GJB6 
gene, associated with a trans mutation in the GJB2 gene 
in the heterozygous cases24. Most genetic cases of hearing 
impairment result from mutations in a single gene, but an 
increasing number of cases with two involved genes have 
been identified31. A multicenter study conducted in nine 
countries demonstrated that the Delta (GJB6-D13S1830) 
mutation is more frequent in France, Spain, Israel, the 
United Kingdom and Brazil, varying from 5.9% to 9.7% 
of all studied alleles of patients with DFNB1, and being 
present in about 50% of heterozygous patients in Spain32. 
In the present study, a 3% prevalence of the deletion in 
the GJB6 gene in heterozygosis with the 35delG mutation 
was found, which is in agreement with data from the 
literature24,32.
In Brazil, a study conducted in newborns from the 
region of Sao Jose do Rio Preto, SP33, found a 2.24% (1:44.6) 
prevalence of heterozygotes for the 35delG mutation, and 
another newborn screening, performed in the region of 
Campinas, SP34, found a 0.97% (1:103) prevalence of he-
terozygotes. In another study, performed in patients with 
hearing loss, mutations in the GJB2 gene were found in 
33.5% of cases, and only the 35delG mutation was iden-
tified in 84.2% of mutant alleles14. The methodology used 
in the current study, AS-PCR and automated sequencing, 
was similar to the three above mentioned researches, but 
a variation was found in the frequency of the alleles with 
the 35delG mutation. This finding can be explained by 
differences in the sample or maybe by the highly hetero-
geneous ethnic composition of the Brazilian population, 
with miscegenation among various ethnic groups, mainly 
Caucasoid and African, allowing the occurrence of di-
fferences in prevalence among different regions of the 
country35.
According to the literature, analyses of the GJB2 
gene in patients with hearing impairment frequently 
demonstrate heterozygosis in about 10% to 42% of ca-
ses, in spite of the fact that most of the mutations are 
recessive23,36,37. In this study, we found a 12.1% frequency 
of heterozygous index cases, a result that agrees with the 
literature23,36,37.
According to the audiometric results, in the present 
study the hearing loss was profound in 41.5% of patients, 
severe in 39.0%, and moderate in 19.5%, with a predomi-
nance of the high frequencies (4000-8000 Hz). In patients 
who were homozygous or heterozygous for 35delG, the 
moderate-severe degrees of hearing loss were predomi-
nant, a pattern that is in agreement with the literature17,38,39. 
Patients who are homozygous for 35delG display a large 
variability in the degrees of hearing loss. Most of the au-
tosomal recessive impairments are phenotypically rather 
consistent, even among sibs, a feature that is not observed 
for the GJB2-35del gene, mainly in heterozygous cases. 
This suggests the possibility of other factors modulating 
the expression of the mutant gene40. An intriguing possi-
bility is that there may be a second conexin gene sharing 
functions with the GJB2 gene. It is conceivable that a 
second conexin protein might act as a substitute under 
certain conditions. Maybe there are modifier genes at other 
locations or environmental influences which activate or 
inactivate the promoter regions of the gene. As protein 
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Cx26 is involved in the ion homeostasis of the inner ear, 
some of these patients may be capable of hearing, for they 
present a moderate hearing loss, suggesting the existence 
of alternative or compensatory homeostatic mechanisms. 
Alterations in protein Cx26 can adversely affect the deve-
lopment of the hearing system, resulting in variations of 
the degree of hearing loss or assymmetry38. Environmental 
influences, such as noises and ototoxic drugs, can be addi-
tive or synergists to the defects caused by mutations in the 
GJB2 gene, thus increasing the hearing loss17,38,41.
The clinical evaluations of patients in this study do 
not suggest that environmental causes are the main fac-
tors, considering that an autosomal recessive transmission 
pattern was identified in cases with the 35delG mutation. 
Moreover, upon audiometric testing, these nine patients 
presented non-progressive audiometric findings, similar to 
those of patients described in the literature23,42-44 diagno-
sed with hearing impairment caused by mutation in the 
GJB2 gene. This confirms that the gene is involved in the 
etiology of the hearing loss of patients of this study with 
a phenotypic expression similar to that described in the 
literature23,42-44. In approximately one third of the cases of 
hearing impairment due to mutations in the GJB2 gene, an 
audiometric pattern of progressive hearing loss is found, 
as opposed to the two thirds of cases with the typical non-
progressive pattern. This means that a child with moderate 
hearing loss may progress to profound, and the therapies 
for these two kinds of degrees of hearing loss may be 
different. Families with a child with moderate-severe or 
profound hearing loss can be benefited by an analysis of 
the GJB238 gene.
The 35delG mutation is easy to detect and the test 
is viable. However, since a great part of the patients with 
the 35delG mutation are homozygous, broader analyses 
of the GJB2 gene will be necessary in a high proportion 
of cases, in order to distinguish the common heterozygous 
carriers (healthy carriers) from the heterozygous patients 
with DFNB1. These broader analyses and investigations 
[including analyses of the entire coding region, the promo-
ter region, the non-coding region of the gene and analyses 
of the Delta (GJB6-D13S1830) mutation], as performed 
in the present study, should be oriented by the clinical 
characteristics of DFNB143,45.
According to the literature, molecular tests asso-
ciated to audiometric data can predict that a significant 
number of patients with the 35delG mutation will present 
a moderate-severe hearing loss and others are expected to 
present profound hearing loss29,44,46, as found in this study. 
Thus, in spite of the small casuistic, the audiometric pattern 
was concordant with the literature, enabling us to establish 
a genotype-phenotype correlation in the ten patients of 
the sample (9 index cases and 1 affected relative), i.e., 
the patients with the 35delG mutation presented a mode-
rate-severe to profound, non-progressive hearing loss. A 
multicenter study is however necessary to verify the true 
phenotypic expression related to the 35delG mutation in 
the Brazilian population. Knowledge of the genotype will 
enable physicians, speech therapists, educators, helped by 
clinical geneticists, to provide more adequate counseling 
to parents by evaluating the risk of a future child having 
a similar hearing impairment. Children diagnosed before 
six months of age and submitted to a successful treatment 
with amplification will have a much greater chance of 
normally developing speech and language.
REFERENCES 
 1. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y 
Acad Sci 1991;630:16-31.
 2. Mustafa T, Arnos KS, Pandya A. Advances in hereditary deafness. 
Lancet 2001;358:1082-90.
 3. Skvorak Giersch AB, Morton CC. Genetic causes of nonsyndromic 
hearing loss. Curr Opin Pediatr 1999;11(6):551-7.
 4. Petit C. Genes responsible for human hereditary deafness: symphony 
of a thousand. Nature Genet 1996;14:385-91.
 5. Van Camp G, Willems PJ, Smith RJH. Nonsyndromic hearing impair-
ment: unparalleled heterogeneity. Am J Hum Genet 1997;60:758-
64.
 6. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang, JN, Parry G, 
Mueller, RF, Leigh IM. Connexin 26 mutations in hereditary non-
syndromic sensorineural deafness. Nature 1997;387:80-3.
 7. Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, 
Kimberling WJ. Novel mutations in the connexin 26 gene (GJB2) that 
cause autossomal recessive (DFNB1) hearing loss. Am J Hum Genet 
1998;62:792-9.
 8. Scott DA, Kraft ML, Carmi R, Ramesh A, Elbedour K, Yari Y, Srisaila-
pathy CRS, et al. Identification of mutation on the connexin 26 gene 
that cause autossomal recessive nonsyndromic hearing loss. Hum 
Mutat 1998;11:387-94.
 9. Gabriel H, Kupsch P, Sudendey Jr, Winterhager E, Jahnke K, et al. 
Mutations in the connexin 26/GJB2 gene are the most common event 
in non-syndromic hearing loss among the German population. Hum 
Mutat 2001;17:521-2.
10. Van Camp G, Smith RJH. Na Hereditary Hearing Loss Homepage [Site 
na Internet]. Disponível em: http://webhost.ua.ac.be/hhh/. Acessado 
em 2006.
11. Zelante L, Gasparini P, Estivill X, Melchionda S, D’Agruma L, Govea 
N, Mila M, Della Monica M, et al. Connexin 26 mutations associated 
with the most common form of non-syndromic neurosensory autos-
somal recessive deafness (DFNB1) in Mediterraneans. Hum Molec 
Genet 1997;6:1605-9.
12. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D’Agruma L, 
Mansfield E, Rappaport E, et al. Connexin 26 mutations in sporadic 
and inherited sensorineural deafness. Lancet 1998;351:394-8.
13. Antoniadi T, Gronskov K, Sand A, Pampanos A, Brondum-Nielsen 
K, Petersen MB. Mutation analysis of the GJB2 (connexin 26) gene 
by DGGE in greek patients with sensorineural deafness. Hum Mutat 
2000;16:7-12.
14. Oliveira CA, Maciel-Guerra AT, Sartorato EL. Deafness resulting from 
mutations in the GJB2 (connexin 26) gene on Brazilian patients. Clin 
Genet 2002;61:354-8.
15. Kammen-Jolly K, Ichiki H, Scholtz AW, Gsenger M, Kreczy A, Schrott-
Fischer A. Connexin 26 in human fetal development of the inner ear. 
Hear Res 2001;160(1-2):15-21.
16. Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, Garabedian EN, 
Petit C. Clinical features of the prevalent form of childhood deafness, 
DFNB1, due to a connexin 26 gene defect: implications for genetic 
counselling. Lancet 1999;17(9161):1298-303.
17. Cryns K, Orzan E, Murgia A, Huygen PLM, Moreno F, del Castilo 
783
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 73 (6) NOVEMBER/DECEMBER 2007
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
I, et al. A genotype-phenotype correlation for GJB2 (connexin 26) 
deafness). J Med Genet 2004;41:147-54.
18. World Health Organization. Report of the informal working group on 
prevention of deafness and hearing impairment programme planning. 
Geneva: WHO, 1991. 22p
19. Antoniadi T, Gronskov K, Sand A, Pampanos A, Brondum-Nielsen 
K, Petersen MB. Mutation analysis of the GJB2 (connexin 26) gene 
by DGGE in Greek patients with sensorineural deafness. Hum Mutat 
2000;16:7-12.
20. del Castillo I, Villamar M, Moreno-Pelayo MA, del Castillo FJ, Alvarez 
A, Telleria D, et al. A deletion involving the connexin 30 gene in 
nonsyndromic hearing impairment. N Engl J Med 2002;346:243-9.
21. Kelley PM, Harris DJ, Comer BC, Askew JW, Fowler T, Smith SD, 
Kimberling WJ. Novel mutations in the connexin 26 gene (GJB2) that 
cause autossomal recessive (DFNB1) hearing loss. Am J Hum Genet 
1998;62:792-9.
22. Sobe T, Vreugde S, Shahin H, Berlin M, Davis N, et al. The prevalence 
and expression of inherited connexin 26 mutations associated with 
non-syndromic hearing loss in the Israeli population. Hum Genet 
2000;106:50-7.
23. Wilcox SA, Saunders K, Osborn AH, Arnold A, Wunderlich J, et al. 
High frequency hearing loss correlated with mutations in the GJB2 
gene. Hum Genet 2000;106:399-405.
24. del Castillo I, Villamar M, Moreno-Pelayo MA, del Castillo FJ, Alvarez 
A, Telleria D, et al. A deletion involving the connexin 30 gene in 
nonsyndromic hearing impairment. N Engl J Med 2002;346:243-9.
25. Frei K, Szuhai K, Lucas T, Weipoltshammer K, Schofer C, Ramsebner 
R, et al. Connexin 26 mutations in cases of sensorineural deafness in 
eastern Austria. Eur J Hum Genet 2002;10:427-32.
26. Pampanos A, Economides J, Iliadou V, Neou P, Leotsakos P, Voyiat-
zis, et al. Prevalence of GJB2 mutations in prelingual deafness in the 
Greek population. Int J Pediatr Otorhinolaryngol 2002;65:101-8.
27. Gasparini P, Estivill X, Volpini V, Totaro A, Castellvi-Bel S, et al. Linka-
ge of DFNB1 to non-syndromic neurosensory autosomal-recessive 
deafness in Mediterranean families. Eur J Hum Genet 1997;5:83-8.
28. Estivill X, Fortina P, Surrey S, Rabionet R, Melchionda S, D’Agruma L, 
Mansfield E, Rappaport E, et al. Connexin 26 mutations in sporadic 
and inherited sensorineural deafness. Lancet 1998;351:394-8.
29. Kenna MA, Wu B-L, Cotanche DA, Korf BR, Rehm HL. Connexin 26 
studies in patientes with sensorineural hearing loss. Arch Otolaryngol 
Head Neck Surg 2001;127:1037-42.
30. Simsek M, Al-Wardy N, Al-Khayat A, Shanmugakonar M, Al-Bulushi 
T, Al-Khabory M, et al. Absence of deafness associated connexin 
26 (GJB2) gene mutations in the Omani population. Hum Mutat 
2001;18:545-6.
31. Nance WE. The genetics of deafness. Ment Retard Disabil Res Rev 
2003;9:109-19.
32. del Castillo I, Moreno-Pelayo MA, del Castillo FJ, Brownstein Z, 
Marlin S, Adina Q, et al. Prevalence and Evolutionary Origins of the 
del(GJB6-D13S1830) Mutation in the DFNB1 Locus in Hearing Impai-
red Subjects: a Multicenter Study. Am J Hum Genet 2003;73:1452-8.
33. Piatto VB, Oliveira CA, Alexandrino F, Pimpinati CJ, Sartorato EL. 
Perspectivas para triagem auditiva genética: rastreamento da mutação 
35delG em neonatos. J Pediatr 2005;81:139-42.
34. Sartorato EL, Gottardi E, Oliveira CA, Magna LA, Annichio-Bizzacchi 
JM, Seixas CA, Maciel-Guerra AT. Determination of the frequency of 
the 35delG in Brazilian neonates. Clin Genet 2000;58:339-40.
35. Oliveira CA, Alexandrino F, Abe-Sandes K, Silva Jr WA, Maciel-Guerra 
AT, Magna LA, Sartorato EL. Frequency of 35delG in the GJB2 gene 
in samples of Caucasians, Asians and African Brazilians. Hum Biol 
2004;76:313-6.
36. Pandya A, Arnos KS, Xia XJ, Welch KO, Blanton SH, Friedman TB, 
et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 
(connexin 30) mutations in a large North American repository of deaf 
probands. Genet Med 2003;5:295-303.
37. Stevenson VA, Ito M, Milunsky JM. Connexin-30 deletion analysis in 
connexin-26 heterozygotes. Genet Test 2003;7:151-4.
38. Cohn ES, Kelley PM, Fowler TW, Gorga MP, Lefkowitz, et al. Clinical 
studies of families with hearing loss attributable to mutations in the 
connexin 26 gene (GJB2/DFNB1). Pediatrics 1999;103:546-50.
39. Murgia A, Orzan E, Polli R, Martella M, Vinazi C, Leonardi E, Arslan E, 
Zacchello F. Cx26 deafness: mutation analysis and clinical variability. 
J Med Genet 1999;36:829-32.
40. Marlin S, Garabedian E-N, Roger G, Moatti L, Matha N, Lewin P, Petit 
C, Denoyelle F. Connexin 26 gene mutations in congenitally deaf 
children. Arch Otolaryngol Head Neck Surg 2001;127:927-33.
41. Rabionet R, Zelante L, Lopez-Bigas N, DAgruma L, Melchionda S, Res-
tagno G, et al. Molecular basis of childhood deafness resulting from 
mutations in the GJB2 (connexin 26) gene. Hum Genet 2000;106:40-
4.
42. Cohn ES, Kelley PM. Clinical phenotype and mutations in connexin 
26 (DFNB1/GJB2), the most commom cause of childhood hearing 
loss. Am J Med Genet 1999;89:130-6.
43. Denoyelle F, Marlin S, Weil D, Moatti L, Chauvin P, Garabedian EN, 
Petit C. Clinical features of the prevalent form of childhood deafness, 
DFNB1, due to a connexin 26 gene defect: implications for genetic 
counselling. Lancet 1999;17:1298-303.
44. Engel-Yeger B, Zaaroura S, Zlotogora J, Shalev S, Hujeirat Y, Car-
rasquilo M, Barges S, Pratt H. The effects of a connexin 26 mutation 
- 35delG - an oto-acoustic emissions and brainstem evoked potentials: 
homozygotes and carriers. Hear Res 2002;163:93-100.
45. Mustapha M, Salem N, Delague V, Chouery E, Ghassibeh M, Rai M, 
Loiselet J, Petit C, Megarbane A. Autosomal recessive non-syndromic 
hearing loss in the Libanese population: prevalence of the 30delG 
mutation and report of two novel mutations in the connexin 26 (GJB2) 
gene. J Med Genet 2001;38:e36.
46. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language 
of early-and later-identified children with hearing loss. Pediatrics 
1998;102:1161-71.
